As of March 2025 Blueprint Medicines has a market cap of โน498.79 Billion. This makes Blueprint Medicines the world's 2433th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Mar 12th, 2025 the market cap of Blueprint Medicines was reported to be: